Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer
The purpose of this study is to determine if the combination therapy of Hormone, Paclitaxel and Radiation therapy are effective in treatment of locally advanced prostate cancer
Prostate Cancer
DRUG: Hormone Suppressors|DRUG: Paclitaxel|RADIATION: Radiation Therapy
Maximum tolerated dose (MTD) assessment, The MTD will be the lowest dose at which 2/6 or 2/3 patients experience dose limiting toxicity (DLT), 8 weeks|Number of participants with qualitative and quantitative toxicities, up to 8 months
The purpose of this study is to determine if the combination therapy of Hormone, Paclitaxel and Radiation therapy are effective in treatment of locally advanced prostate cancer